Eupraxia Pharmaceuticals Inc opened trading today at $4.24 and closed at $3.80. prices ranged from $3.75 to $4.24.

Shares shrank -4.04 percent from the previous day's close of $3.96.

Today across North America, the TSX Composite closed -0.02% at 22260.30, the S&P 500 closed -0.04% at 5202.39, the Dow Jones Industrial Average closed -0.03% at 38892.80 and the Nasdaq Composite closed 0.03% at 16253.96.

Eupraxia Pharmaceuticals Inc has listed on the Toronto Stock Exchange (TSX) under the ticker EPRX.

Trading volume was 60,200 on 216 total trades. On average, Eupraxia Pharmaceuticals Inc has traded 84,171 shares in the last five days and 55,835 year-to-date.

Trading across the entire TSX saw 2,909 price advancers against 2,322 declines and 125 unchanged.

During the prior 52 weeks, EPRX.TO has traded as high as $9.10 (July 05,2023) and low as $3.75 (April 09,2024). Moreover, the shares have eased -11.42 percent in 52 weeks, while they have shrunken -29.24% since the start of 2024.

Following today's trading, Eupraxia Pharmaceuticals Inc has a market capitalization of $141.06 million on a float of 35,623 shares outstanding. Its annual EPS is $-1.53.

Eupraxia Pharmaceuticals Inc is a TSX Biotechnology company headquartered in Victoria, CAN.

Currently, Eupraxia Pharmaceuticals Inc's consensus rating is "Strong Sell" based on 0 analysts according to Zacks. Currently, there are for the stock.

AI at The Globe and Mail
This report is produced using automated technology that summarizes market data into articles for our readers. Ongoing project experiments that leverage artificial intelligence include valuation screens across 14 categories and end-of-day Closing Summary reports for all North American securities..